Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1984 1
1988 3
1989 2
1991 5
1992 3
1993 1
1995 1
1996 3
1997 1
1998 3
1999 2
2001 2
2002 2
2003 2
2004 4
2005 7
2006 8
2007 3
2008 6
2009 9
2010 7
2011 4
2012 11
2013 14
2014 16
2015 12
2016 11
2017 22
2018 24
2019 20
2020 22
2021 19
2022 19
2023 29
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20RJ, 5BAuthor
Page 1
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE; PD MED Collaborative Group. Gray R, et al. JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736. JAMA Neurol. 2022. PMID: 34962574 Free PMC article. Clinical Trial.
With regard to DRIs, participants in the MAO-B group had mean PDQ-39 mobility scores that were 4.2 points (95% CI, 0.4-7.9 points; P=.03) better than those of the COMT group and EuroQol 5-dimension 3-level (EQ-5D-3L) utility scores that were 0.05 points (95% CI, 0.003-0.09 …
With regard to DRIs, participants in the MAO-B group had mean PDQ-39 mobility scores that were 4.2 points (95% CI, 0.4-7.9 points; P=.03) be …
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
PD Med Collaborative Group; Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. PD Med Collaborative Group, et al. Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Lancet. 2014. PMID: 24928805 Clinical Trial.
PDQ-39 mobility scores were 1.4 points (95% CI 0.0-2.9, p=0.05) better in patients allocated MAOBI than in those allocated dopamine agonists. EQ-5D utility scores averaged 0.03 (95% CI 0.01-0.05; p=0.0002) better with levodopa than with levodopa-sparing therapy; rates of d …
PDQ-39 mobility scores were 1.4 points (95% CI 0.0-2.9, p=0.05) better in patients allocated MAOBI than in those allocated dopamine agonists …
What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews.
Finch AP, Brazier JE, Mukuria C. Finch AP, et al. Eur J Health Econ. 2018 May;19(4):557-570. doi: 10.1007/s10198-017-0902-x. Epub 2017 May 30. Eur J Health Econ. 2018. PMID: 28560520 Free PMC article. Review.
OBJECTIVE: To assess the evidence on the validity and responsiveness of five commonly used preference-based instruments, the EQ-5D, SF-6D, HUI3, 15D and AQoL, by undertaking a review of reviews. ...The body of evidence, covering more than 180 studies, was heavily skewed to …
OBJECTIVE: To assess the evidence on the validity and responsiveness of five commonly used preference-based instruments, the EQ-5D, S …
Aneurysm growth, survival, and quality of life in untreated thoracic aortic aneurysms: the effective treatments for thoracic aortic aneurysms study.
Sharples L, Sastry P, Freeman C, Bicknell C, Chiu YD, Vallabhaneni SR, Cook A, Gray J, McCarthy A, McMeekin P, Vale L, Large S. Sharples L, et al. Eur Heart J. 2022 Jul 1;43(25):2356-2369. doi: 10.1093/eurheartj/ehab784. Eur Heart J. 2022. PMID: 34849716 Free PMC article.
Outcomes were aneurysm growth, survival, quality of life (using the EQ-5D-5L utility index), and hospital admissions. Between 2014 and 2018, 886 patients were recruited from 30 NHS vascular/cardiothoracic units. ...
Outcomes were aneurysm growth, survival, quality of life (using the EQ-5D-5L utility index), and hospital admissions. Between 2014 an …
Humanistic and cost burden of systemic sclerosis: A review of the literature.
Fischer A, Zimovetz E, Ling C, Esser D, Schoof N. Fischer A, et al. Autoimmun Rev. 2017 Nov;16(11):1147-1154. doi: 10.1016/j.autrev.2017.09.010. Epub 2017 Sep 9. Autoimmun Rev. 2017. PMID: 28899803 Free article. Review.
METHODS: A structured review of the literature was conducted, using predefined search strategies to search PubMed, Embase, and the Cochrane Library. Grey literature searches also were conducted. RESULTS: In total, 2226 articles were identified in the databases and 52 were …
METHODS: A structured review of the literature was conducted, using predefined search strategies to search PubMed, Embase, and the Cochrane …
Differences in utility elicitation methods in cardiovascular disease: a systematic review.
Blieden Betts M, Gandra SR, Cheng LI, Szatkowski A, Toth PP. Blieden Betts M, et al. J Med Econ. 2018 Jan;21(1):74-84. doi: 10.1080/13696998.2017.1379410. Epub 2017 Oct 10. J Med Econ. 2018. PMID: 28899233 Free article. Review.
MATERIALS AND METHODS: This review identified English-language articles in Embase, MEDLINE, and the gray literature published between September 1992 and August 2015 using keywords for "utilities" and "stroke", "heart failure", "myocardial infarction", or "angina". ...Withi …
MATERIALS AND METHODS: This review identified English-language articles in Embase, MEDLINE, and the gray literature published between …
Unbiased Measure of General Quality of Life in Chronic Rhinosinusitis Reveals Disease Modifiers.
Epperson MV, McCann AC, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR. Epperson MV, et al. Laryngoscope. 2021 Jun;131(6):1206-1211. doi: 10.1002/lary.29139. Epub 2020 Oct 2. Laryngoscope. 2021. PMID: 33006402
We sought to identify characteristics of CRS patients with a high EQ-5D HUV but low EQ-5D VAS score. MATERIALS AND METHODS: Retrospective cross-sectional study of 300 CRS patients with EQ-5D HUV equal to 1.0 (reflecting perfect health). ...In CRS patients wit …
We sought to identify characteristics of CRS patients with a high EQ-5D HUV but low EQ-5D VAS score. MATERIALS AND METHODS: Re …
Xenopus Tadpole Craniocardiac Imaging Using Optical Coherence Tomography.
Deniz E, Mis EK, Lane M, Khokha MK. Deniz E, et al. Cold Spring Harb Protoc. 2022 Jun 7;2022(5):Pdb.prot105676. doi: 10.1101/pdb.prot105676. Cold Spring Harb Protoc. 2022. PMID: 34031211
OCT is analogous to ultrasound, utilizing light instead of sound to create a gray-scale image from the echo time delay of infrared light reflected from the specimen. ...
OCT is analogous to ultrasound, utilizing light instead of sound to create a gray-scale image from the echo time delay of infrared li …
Responsiveness and minimal clinically important difference for the EQ-5D in chronic rhinosinusitis.
Hoehle LP, Phillips KM, Speth MM, Caradonna DS, Gray ST, Sedaghat AR. Hoehle LP, et al. Rhinology. 2019 Apr 1;57(2):110-116. doi: 10.4193/Rhin18.122. Rhinology. 2019. PMID: 30175337
Our objective was to determine the responsiveness and minimal clinically important difference (MCID) of the EQ-5D health utility value (EQ-5D HUV) and visual analog scale (EQ-5D VAS) in chronic rhinosinusitis (CRS). ...RESULTS: Change in SNOT-22 score was cor …
Our objective was to determine the responsiveness and minimal clinically important difference (MCID) of the EQ-5D health utility valu …
280 results